Tharimmune
Biotechnology company developing novel immunotherapies for cancer.
About
Canton Strategic Holdings is the first publicly traded company leveraging Canton Coin and supporting the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. They operate a Super Validator for the Network, ensuring secure transactions, and are focused on the tokenization of real-world assets. The company serves institutional investors and participants in the financial markets. Teams look it up for Biotech, MedTech, HealthTech.
Frequently asked
What does Tharimmune do?
Tharimmune is a Biotech company that offers Services. Teams look it up for MedTech, HealthTech, Drug Discovery. It is based in Cambridge, United States and was founded in 2017. Public records show about 13 people and $540M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Tharimmune raised?
Tharimmune has raised a total of $540M in funding.
Where is Tharimmune headquartered?
Tharimmune is headquartered in Cambridge, United States.
When was Tharimmune founded?
Tharimmune was founded in 2017.
What industry does Tharimmune operate in?
Tharimmune operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials.
How many employees does Tharimmune have?
Tharimmune has approximately 13 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.